书签 分享 收藏 举报 版权申诉 / 66
上传文档赚钱

类型-血脂检测临床应用的有关问题课件.ppt

  • 上传人(卖家):ziliao2023
  • 文档编号:5934476
  • 上传时间:2023-05-16
  • 格式:PPT
  • 页数:66
  • 大小:610KB
  • 【下载声明】
    1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
    2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
    3. 本页资料《-血脂检测临床应用的有关问题课件.ppt》由用户(ziliao2023)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
    4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
    5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
    配套讲稿:

    如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。

    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    血脂 检测 临床 应用 有关 问题 课件
    资源描述:

    1、 Plasma lipidsPlasma lipoproteinLDLLp(a)VLDLHDLstructure of lipoproteinClinical items for lipids detectionCinical items for lipids analysis(2)nFFAnCerebroside esterceramidenSphingenine SphingomyelinnGalactode-cerebrosideGenotype n ApoE genotype ApoCIII genotypen ApoCII genotype Apo(a)genotype n LDLR

    2、 genotype VLDLR genotypen HMGCoAR genotype SR genotypeCinical items for lipids analysis(3)Behaviour factors(1)unsaturated fatty acid saturated fatty acid Behaviour factors(2)TG,TC and LDL-C HDL-C Lost weight TG(40)TC(10)LDL-C(10)HDL-C(10)TG,LDL-C and Lp(a)apoA and HDL-C HDL-C Behaviour factors(3)Beh

    3、aviour factors(4)nHDL-C,apoA,apoA(1.2 oz/d or 34g/d)nPrimry hypertriglyceridemia with mild drinking can lead to the level of TG increased further.nAlcohol has different effects on Lp(a)from other lipids.at the begin Lp(a)33%six weeks later Lp(a)back to initial levelnProper drinking red wine can decr

    4、ease the level of Lp(a).Behaviour factors(5)nCoffeeTC and LDL-C apoA,apoA,apoB and HDL-C seemed not be affected.nTension TC Hospitalization HDL-C and apoA(10)Behaviour factors(6)Exercise TG、LDL-C and apoB HDL-C and apoA The degree was related to the kinds of sports and intensity.Intense exercises ca

    5、n increase the level of HDL-C obviously.Moderate regular exercises was a ideal way to decrease the level of blood lipid.Normal exercises have no influences on the level of Lp(a),while intense physical activity can increase the level of Lp(a)by 1015.Clinical factors therapeutic drugs(1)nfor example t

    6、hiagine(diuresis drug)can increase the level of TC,LDL-C,TG and apoB by 12%、20%,7%,20%respectively,decrease the leval of apoAI and HDL-C by 6%and 16%.nBeta-neg(receptor blocker)can increase the level of TG and decrease the leval of HDL-C.nOral taking contraceptive with progesterone can increase the

    7、leval of TC and LDL-C,and decrease the leval of HDL-C.nEstrin treatment can decrease the leval of Lp(a)by 50%.nImmunosuppressive agentClinical factors therapeutic drugs(2)The division of abnormal lipids level Risk rateTC and CHD Plasma TC Medical decision level for lipid assay mmol/L(mg/dl)The class

    8、ification of lipid level in ATP-III of the American National choleterol education project,mmol/L(mg/dl)Blood lipid Unit conversion for clinical routine of lipid items (primitive unit legal unit)The application of clinical lipid assayClinical significance of lipid assay(1)Clinical significance of lip

    9、id assay(2)Diseases affecting the level of TC Cinical significance of lipid assay(2)Hypertriglyceridemia drugnHowever,in familial combined hyperlipidemia,both the ApoA1 and HDL-C decreased lightly and they increased the risk of CHD.Cinical significance of lipid assay(3)Cinical significance of lipid

    10、assay(4)Cinical significance of lipid assay(5)nephrotic syndrome,pregnancy and so onCinical significance of lipid assay(6)Cinical significance of lipid assay(7)?HDLLDLVLDLIDLLp(a)RLPIm goodIf treatable,were not that bad!Plasma HDL-C level was affected by following diseases hereditary Lipid metabolic

    11、 disorder lipoprotein gene deficiency lipoprotein receptor gene deficiency lipid metabolic enzyme gene deficiency cytolysosome lipid metabolism enzyme gene deficiencyCinical significance of lipid assay(8)for instance:Lysosomal hydrolase hereditary defect ,phospholipid metabolism disorder were very c

    12、ommon.Gene analysis of lysosomal storage disease The Structure and Function of Lysosome Lysosome was such a kind of organelle like a film in the cell,with a cystiform structure,and it contained many kinds of hydrolase,it worked so that it can break down many kinds of endogenous and exogenous substan

    13、ce,so it was also considered as a peptic in the cell.Phospholipid could be divided into glycerophospholipide and sphingolipid;the latter could be divided into sphingomyelin and glycosylsphingolipid.The lysosome contained about 50 kinds of hydrolase,such as protease,nuclease,glycosidase,lipase,phosph

    14、atase,phosphonolipidase and sulfatidase etc.鞘脂代谢Sphingolipid metabolismLysosomal lipids storage disordersdiseaseClinical symptom(Fucosidosis)(Fucosidase)gene locus:1p34Cer-Glc-Gal-GalNAc-Gal-FucH-alloantigen(H-lsoantigen)cerebrum degenerate,Convulsive tic,(Generalized gangliosidosis)(GM1-galactosida

    15、se)gene locus:3pter-p21Cer-Glc-Gal(NeuAc)-GalNA-Gal(GM1Ganglioside)mental aphrenia,skeleton deform hepatauxe,(Tay-Sachs disease)(Hexosaminidase A)gene locus:15q13.1Cer-Glc-Gal(NeuAc)-GalNAc(GM2Ganglioside)mental aphrenia,acroisa amyastheniaMetachromatic leukodystrophy,MLD)(Arysulfatase A)gene locus:

    16、10q21.1Cer-Gal-OSO3(3-suffogalactosyl-ceramide)mental aphrenia,mental retardate in adult,demyelination(Krabbes disease)(-Galactosidase)gene locus:14q31 Cer-Gal(Galactosylceramide)mental aphrenia:nearly no myelin(Gaucher disease,GD)(-Glucosidase,-glu)gene locus:1q21.1Cer-Glc(Glucosylceramidsplenohepa

    17、tomegalia,Bone causticize,mental retardate in youge child(Niemann-Pick disease)(Sphingomyelinase,ASM)gene locus:11p15.1-p15.4Cer-_P-(Sphingomyelin)splenohepatomegalmental retardateDie in youge child(Farber disease,)(Ceramidase)Acyl-(Ceramide)Acyl-(Ceramide)NeuAc,(N-acetylneuraminic acid);Cer,(cerami

    18、de);Glc,(glucose);Gal,(galactose);Fuc,(fucose);-enzyme action site plete physical examination 2.cytological examination of marrow and peripheral blood cells mainly finding the large foam cells.3.determination of routine biochemical indicator especially the lipid level and functional examination of l

    19、iver and kidney.Laboratory diagnosis of hereditary lysosomal lipids storage diseaseGaucher cell Niemann-Pick cell?4.lysosomal enzyme activity assayvChitotriosidase,CT To identify diagnosis of Lipids Storage Disease Gaucher disease increased lightly Niemann-Pick disease more than 100 timesvSphingomye

    20、linase To confirm the diagnosis of Niemann-Pick disease.vGlucocerebrosidase To Confirm the diagnosis of Gaucher disease.5.High performance liquid chromatogram,HPLC To analyze the composition of lipids To detect the enzymes activity 6.Physical examination To check up the pathological changes of liver

    21、,spleen,skeleton and brain.7.Gene analysis If the basic mutations resulted in the substitution of amio acids or the nucleotide depletions and/or insertions were identified,you can get a final diagnosis.The lipid detection while the level of TC was normalLipoproteins which resulted in AS n CM and VLD

    22、L remnantsn Modified LDLn Small dense LDL n Lp(a)LiverArteryTransportation of TCPhysiological functions of HDL and LDLTransportation of TC Non-HDL-C The standard value and target value for hyperlipidimia received treatment (China 1997)AS(-)Other risk factor(-)AS(-)factor(+)AS(+)The target value of T

    23、LC and drug therapy in different kind of CHD (ATP 2001)Risk classification LDL-C LDL-C LDL-C target value onset of TLC considering drug treatmentCHD or other danger sign 20%)100mg/dl considering if drug treatment needed2 risk factor 10 years-risk 10%-20%10 years-risk 20%130mg/dl 130mg/dl 10 years-ri

    24、sk 10%(01 risk factor 190mg/dl 160mg/dl 160mg/dl considering ifdrug treatment needed The target value and cutoff value for drug treatment and TLC at different risk in the modified ATP III based on recent evivence of clinical trials.NCEP Report.Circulation.2004:110;227-39Risk categary LDL-C goalonset

    25、 of TLCconsidering drug treatmentSeveral incorrect conceptsReasonable selection and application of lipid items(1)Reasonable selection and Application of lipid items(2)Reasonable selection and Application of lipid items(3)HDL-C and ApoAI shoud not replace with each other LDL-C and ApoB shoud not substitute for each other Risk factors diagnostic criteria Administration of hyperlipidemia in children fasting conditions,hemoconcentration,use of anticoagulants and preservatives,capillary blood against venesection,and storage conditions of the specimen etc.

    展开阅读全文
    提示  163文库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:-血脂检测临床应用的有关问题课件.ppt
    链接地址:https://www.163wenku.com/p-5934476.html

    Copyright@ 2017-2037 Www.163WenKu.Com  网站版权所有  |  资源地图   
    IPC备案号:蜀ICP备2021032737号  | 川公网安备 51099002000191号


    侵权投诉QQ:3464097650  资料上传QQ:3464097650
       


    【声明】本站为“文档C2C交易模式”,即用户上传的文档直接卖给(下载)用户,本站只是网络空间服务平台,本站所有原创文档下载所得归上传人所有,如您发现上传作品侵犯了您的版权,请立刻联系我们并提供证据,我们将在3个工作日内予以改正。

    163文库